Teemu Suna

Interviewed by @gemmamilne for @Forbes: If something fails, it doesn’t prove that someone else cannot make it work - @NgaleHealth looking beyond Theranos #344e84a620a4" target="_blank" rel="nofollow noopener">forbes.com/sites/gemmamil…

@AnttiLuiro @Vuornos @NgaleHealth Ikä+sukupuoli+pieni määrä verta riittää ja tarjoaa huipputason kansansairauksien riskintunnistuskyvyn nature.com/articles/s4159…  3/3

@AnttiLuiro @Vuornos @NgaleHealth Silloin kuormitus pienenee, syntyy säästöjä ja parempaa terveyttä. Nightingale lienee yksi erittäin harvoista realistisista ratkaisuista joka on kansalliseen käyttöön riittävän edullinen, operatiivisesti yksinkertainen. 2/3

Sosiaali- ja terveydenhuollossa on historiallinen työvoimapula. Pääosin terveiden ihmisten terveystarkastukset ovat todella tehotonta resurssien käyttöä ja pahentaisivat henkilöstöpulaa hoivassa ja terveydenhuollossa. iltalehti.fi/politiikka/a/1…

We've launched Livit by Nightingale Health. From a finger-prick sample, we deliver our new Healthy Years estimate together with a wide variety of other health metrics that not only measure your current health but also predict the future of your health. vimeo.com/694065020/e22a…

We are redefining global primary care by empowering people with modern preventative health tools - read more👇🏼

🎙️ This week's podcast is with #HealthTransformer @teemusuna, CEO & Co-founder of @NgaleHealth, who shared how Nightingale's blood-testing technology could change preventative health #globally. Listen here! ow.ly/am1450HQVi6

Indeed - however, this needs to be built for mass market and we @NgaleHealth are already on it! 💪

Earlier today, we held a virtual event, An hour with Nightingale, where our CEO @teemusuna and CSO @jcbarret shared our most recent research and development achievements. Watch the recording: nightingalehealth.videosync.fi/an-hour-with-n…

We're excited to have @SamuMyllykangas and @teemusuna join #TEHDASforum on 27 October. They will share how their companies utilise #healthdata, how they overcame barriers to data use, and how they see data changing healthcare. Register today! tehdas.eu/event/stakehol…

Exciting news & important step in our global expansion plan - great work Team Nightingale! 💪

Nightingale’s Financial Statement Release is out. Great delivery, speed & progress in key strategic iniatives. Thank you Team Nightingale, fantastic job (once again)!

Millä tolalla on tuoreen pörssiyhtiön toimitusjohtajan terveys? Katso haastattelun alussa miten Nightingalen testi paljastaa totuuden pintaa syvemmältä. youtu.be/uomTbA_Qruw

Delighted to have @jcbarret join Nightingale as Chief Scientific Officer to accelerate our mission to bring preventative health tools available worldwide.

Nightingalen listautumisanti on ylimerkitty ja listautuminen toteutetaan suunnitellusti – B-sarjan osakkeiden kaupankäynnin odotetaan alkavan perjantaina 19.3.2021 nightingalehealth.com/news/nightinga…

The IPO of Nightingale has been oversubscribed and the listing will be completed as planned – trading in the series B shares is expected to commence on Friday 19 March 2021 nightingalehealth.com/news/nightinga…

Nightingale intends to launch an IPO and listing on Nasdaq First North Growth Market Finland. Read more: nightingalehealth.com/news/nightinga…

Nightingale Health suunnittelee listautumista Nasdaq Helsingin First North markkinapaikalle. Lue lisää: nightingalehealth.com/news/nightinga…

@teslaownersSV Well, back to work …

#BigNews Nightingale has appointed Swedbank AB as the lead financial advisor to explore different financing options, including possibilities of an Initial Public Offering by listing the Company’s shares on Nasdaq Helsinki First North. Details: nightingalehealth.com/news/nightinga…

Matka kohti pörssiä alkaa @NgaleHealth news.cision.com/nightingale-he…